Takashi Kojima

1985–2026 年に発表

223
論文数
24,929
被引用数
90
h 指数
201
i10 指数

被引用数

Takashi Kojima の年別被引用数1986 年: 被引用 2 件1987 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 3 件1992 年: 被引用 6 件1993 年: 被引用 6 件1994 年: 被引用 5 件1995 年: 被引用 3 件1996 年: 被引用 4 件1997 年: 被引用 8 件1998 年: 被引用 12 件1999 年: 被引用 13 件2000 年: 被引用 36 件2001 年: 被引用 34 件2002 年: 被引用 42 件2003 年: 被引用 60 件2004 年: 被引用 74 件2005 年: 被引用 94 件2006 年: 被引用 88 件2007 年: 被引用 121 件2008 年: 被引用 118 件2009 年: 被引用 82 件2010 年: 被引用 97 件2011 年: 被引用 121 件2012 年: 被引用 118 件2013 年: 被引用 131 件2014 年: 被引用 118 件2015 年: 被引用 110 件2016 年: 被引用 104 件2017 年: 被引用 140 件2018 年: 被引用 101 件2019 年: 被引用 488 件2020 年: 被引用 853 件2021 年: 被引用 921 件2022 年: 被引用 950 件2023 年: 被引用 754 件2024 年: 被引用 1,231 件2025 年: 被引用 529 件2026 年: 被引用 9 件1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,796 件、この内訳の 19.4%中国: 引用元論文 1,739 件、この内訳の 18.8%日本: 引用元論文 876 件、この内訳の 9.4%イギリス: 引用元論文 449 件、この内訳の 4.8%ドイツ: 引用元論文 436 件、この内訳の 4.7%イタリア: 引用元論文 358 件、この内訳の 3.9%フランス: 引用元論文 298 件、この内訳の 3.2%スペイン: 引用元論文 282 件、この内訳の 3%韓国: 引用元論文 250 件、この内訳の 2.7%カナダ: 引用元論文 232 件、この内訳の 2.5%オーストラリア: 引用元論文 201 件、この内訳の 2.2%インド: 引用元論文 173 件、この内訳の 1.9%
0%19.4%その他 23.5%

分野

  • Medicine61.2%
  • Biochemistry, Genetics and Molecular Biology14%
  • Neuroscience9.2%
  • Immunology and Microbiology6.2%
  • Physics and Astronomy1.8%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • その他6.4%

トピック

  • Cancer Immunotherapy and Biomarkers7.3%
  • Esophageal Cancer Research and Treatment4.4%
  • Ocular Surface and Contact Lens4.1%
  • Barrier Structure and Function Studies3.1%
  • Gastric Cancer Management and Outcomes2.4%
  • Immunotherapy and Immune Responses1.8%
  • その他76.9%

共著者

全論文

検索で開く
  1. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 1,580

  2. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 1,176

  3. Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 926

  4. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 291

  5. Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer

    著者: , , , , , , , , , , , - ESMO Open 2023 被引用: 161

  6. 36th International Symposium on Intensive Care and Emergency Medicine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amos Douvdevani, Ryosuke Takegawa, Hisao Yoshida, Tomoya Hirose, Naoki Yamamoto, Hideharu Hagiya, Masahiro Ojima, Y. Akeda, Osamu Tasaki, Kazunori Tomono, T. Shimazu, S. Ono, Toshio Kubo, S Suda, T. Ueno, T. Ikeda, Tomoya Hirose, Hiroshi Ogura, Hiroki Takahashi, Masahiro Ojima, J. Kang, Youhei Nakamura, Takashi Kojima, T. Shimazu, T. Ikeda, S Suda, Yoshito Izutani, Takuya Ueno, Satoshi Ono, Tadatsugu Taniguchi, M. O, C. Dinter, J. Lotz, Beth Eilers, Christian Wißmann, Rex S. Lott, Marc Meili, Philipp Schüetz, Hassan Hawa, M. Sharshir, M. Aburageila, Nawal Salahuddin, Vasiliki Chantziara, Sophia Georgiou, Angeliki M. Tsimogianni, Panagiotis Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, Georgia Micha, E. Chinou, G. Michaloudis, A. Kodaira, T. Ikeda, Satoshi Ono, T. Ueno, S Suda, Y. Izutani, Hitoshi Imaizumi, María Victoria de la Torre-Prados, A García-de la Torre, Alfredo Enguix-Armada, A Puerto-Morlán, V. Perez-Valero, Ángel García-Alcántara, N. Bolton, J. Dudziak, Samantha Bonney, Ascanio Tridente, Patrick Née ほか 2,340 名 - Critical Care 2016 被引用: 521

  7. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Esophagus 2023 被引用: 391

  8. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Esophagus 2023 被引用: 188

  9. Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells

    著者: , , , , , - Biochimica et Biophysica Acta (BBA) - Biomembranes 2020 被引用: 174

  10. Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease

    著者: , , , - Investigative Ophthalmology & Visual Science 2018 被引用: 256

  11. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 193

  12. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

    著者: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 被引用: 519

  13. A New Perspective on Dry Eye Classification: Proposal by the Asia Dry Eye Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Eye & Contact Lens Science & Clinical Practice 2019 被引用: 195

  14. Advances in the diagnosis and treatment of dry eye

    著者: , , , , - Progress in Retinal and Eye Research 2020 被引用: 179

  15. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keiko Minashi, Hisahiro Matsubara, Yuji Kikuchi, Ken Kato, Ken Kato, Kosuke Narumiya, Yuko Kitagawa, Yutaro Kubota, Masayuki Watanabe, Masaki Ueno, Soji Ozawa, Takashi Ogata, Takeo Bamba, Hiroshi Ichikawa, Masaya Watanabe, Yasuhiro Tsubosa, Hiroya Takeuchi, Tetsuya Abe, Masahiko Koike, Shigeru Tsunoda, Yuichiro Doki, Hiroshi Miyata, Motohiro Hirano, Hiroko Ikeda, Masahiro Goto, Hironobu Minami, Toru Masuzawa, Masahiro Tsuda, Morihito Okada, Hidenori Mukai, Takeshi Kajiwara, Yuichi Shibuya, Masaru Morita, Eishi Baba, Hideo Baba, Masafumi Inomata, Ken Sasaki - The Lancet 2024 被引用: 230

  16. A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors

    著者: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 113

  17. The Hyper Suprime-Cam SSP Survey: Overview and survey design

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton T. Jaelani, Takashi Hattori, Satoshi Kawanomoto, Masao Hayashi, Yusuke Hayashi, N. Suzuki, Kenneth C. Wong, Bau-Ching Hsieh, Chiaki Hikage, Tomonori Usuda, Nozomu Tominaga, Kuiyun Huang, Hung-Yu Jian, Surhud More, Song Huang, Hiroyuki Ikeda, Haruka Kusakabe, Masatoshi Imanishi, Akio Inoue, Hisakazu Uchiyama, Hitomi Yamanoi, Hiroshi Karoji, Yukiko Kamata, S. H. Suyu, Issha Kayo, Nobunari Kashikawa, Alexie Leauthaud, Atsunori Yonehara, Sogo Mineo, Jin Koda, Yoshiki Matsuoka, Shintaro Koshida, Michitaro Koike, Takashi Kojima, Tomotsugu Goto, Yutaka Komiyama, Elinor Medezinski, Yoshiki Toba, Anupreeta More, Yasushi Suto, Rachel Mandelbaum, Yusei Koyama, Shoken M. Miyama, Wei-Hao Wang, Lee, C.-H., Shiro Mukae, Lihwai Lin, Yen‐Ting Lin, Yuma Sugahara, Robert H. Lupton, Ryoma Murata, M. Tanaka, Naoshi Sugiyama, Hiroko Niikura, Hironao Miyatake, Tomohisa Uchida, Naoyuki Tamura, Y. Urata, Satoshi Miyazaki, Rieko Momose, Yoshihiko Yamada, Joshua S. Speagle, Yuichi Terashima, Atsushi J. Nishizawa, Sakurako Okamoto, Yuki Moritani, Takashi J. Moriya, Hitoshi Murayama, Tomoki Morokuma, Sherry Yeh ほか 44 名 - Publications of the Astronomical Society of Japan 2017 被引用: 1,039

  18. Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 被引用: 254

  19. U3-1402, a Novel HER3-Targeting Antibody–Drug Conjugate, for the Treatment of Colorectal Cancer

    著者: , , , , , , , , , , - Molecular Cancer Therapeutics 2019 被引用: 100

  20. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)

    著者: , , , , , , , , , , , , , , - Esophagus 2022 被引用: 62

  21. Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 被引用: 53

  22. NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 被引用: 61

  23. Transmembrane proteins of tight junctions

    著者: , , , , - Biochimica et Biophysica Acta (BBA) - Biomembranes 2007 被引用: 471

  24. KEYNOTE-590: Phase III Study of First-Line Chemotherapy with or Without Pembrolizumab for Advanced Esophageal Cancer

    著者: , , , , , , , , , , , , , , , - Future Oncology 2019 被引用: 171